Search Results
Test Catalog
URAU - Overview: Urea, 24 Hour, Urine
Assessment of protein intake and/or nitrogen balance
TOPI - Overview: Topiramate, Serum
Monitoring serum concentrations of topiramate Assessing compliance Assessing potential toxicity
URCU - Overview: Uric Acid, 24 Hour, Urine
Assessment and management of patients with kidney stones, particularly uric acid stones
VITE - Overview: Vitamin E, Serum
Monitoring of Vitamin E supplementation/treatment Potentially detecting Vitamin E overdoses
VDSFT - Overview: VDRL Titer, Spinal Fluid
Aid in the diagnosis of neuroinvasive syphilis as part of a profile
VIP - Overview: Vasoactive Intestinal Polypeptide, Plasma
Detecting vasoactive intestinal polypeptide-producing tumors in patients with chronic diarrheal diseases
FC9K - Overview: Factor IX Known Mutation Sequencing
Factor IX Known Mutation Sequencing
PRSSZ - Overview: PRSS1 Gene, Full Gene Analysis, Varies
Confirmation of suspected clinical diagnosis of hereditary pancreatitis (HP) in patients with chronic pancreatitis Identification of familial PRSSI mutation to allow for predictive and diagnostic testing in family members
ANAE - Overview: Bacterial Culture, Anaerobic, Varies
Diagnosing anaerobic bacterial infections
ALPRT - Overview: Alport (Collagen IV Alpha 5 and Alpha 2) Immunofluorescent Stain, Renal Biopsy
Assisting in the diagnosis of hereditary nephritis (Alport syndrome)
AMTRP - Overview: Amitriptyline and Nortriptyline, Serum
Monitoring amitriptyline and nortriptyline serum concentrations during therapy Evaluating potential amitriptyline and nortriptyline toxicity May aid in evaluating patient compliance
RA1U - Overview: Alpha-1-Microglobulin, Random, Urine
Assessment of renal tubular injury or dysfunction using random urine specimens Screening for tubular abnormalities Detecting chronic asymptomatic renal tubular dysfunction (2)
AMPHM - Overview: Amphetamine-Type Stimulants Confirmation, Meconium
Detecting in utero exposure to amphetamine-type stimulants up to 5 months before birth
MMLYP - Overview: Antimicrobial Susceptibility Panel, Yeast, Varies
Determining in vitro quantitative antifungal susceptibility (minimum inhibitory concentration) of non-fastidious yeast As an aid in the management of certain circumstances, such as: -Refractory oropharyngeal infections due to Candida...
ASB - Overview: Arsenic, Blood
Detecting acute or very recent arsenic exposure Monitoring the effectiveness of therapy This test is not useful for evaluation of chronic arsenic exposure.
MMLRG - Overview: Antimicrobial Susceptibility, Acid-Fast Bacilli, Rapidly Growing, Varies
Determination of susceptibility of rapidly growing mycobacteria to the antimicrobial agents on the test panel
AMMO - Overview: Ammonium, 24 Hour, Urine
Diagnosis of the cause of acidosis Diagnosis and treatment of kidney stones
ACT - Overview: Actinomyces Culture, Varies
Diagnosing anaerobic Actinomyces involved in infections
F_9 - Overview: Coagulation Factor IX Activity Assay, Plasma
Diagnosing deficiencies, particularly hemophilia B (Christmas disease) Assessing the impact of liver disease on hemostasis Investigation of a prolonged activated partial thromboplastin time
CTU - Overview: Creatinine, 24 Hour, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine
DIG - Overview: Digoxin, Serum
Monitoring digoxin therapy
PDSUX - Overview: Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is...
DSS - Overview: Drug Screen, Prescription/Over the Counter, Serum
Detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent Qualitatively identifying drugs present in the specimen; quantification of identified drugs, when...
ANCA2 - Overview: Cytoplasmic Neutrophil Antibodies, Inflammatory Bowel Disease Panel, Serum
Measurement of antineutrophil cytoplastic antibodies as a part of a profile to aid in distinguishing between ulcerative colitis and Crohn disease in patients for whom the specific diagnosis is unclear based on endoscopic, pathologic, and...
ECHNG - Overview: Echinococcus Antibody, IgG, Serum
Detection of antibodies to Echinococcus granulosus
CLOM - Overview: Clomipramine, Serum
Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose
BABG - Overview: Babesia microti IgG Antibodies, Serum
An adjunct in the diagnosis of babesiosis Follow-up of documented babesiosis
CYTNG - Overview: Cytology Non-Gynecologic, Varies
Detecting malignant and premalignant changes
FVAG - Overview: Fungal Culture, Vaginal
Monitoring therapy for vulvovaginitis Managing chronic recurring disease Determining the etiology of infectious vaginitis when other tests have been uninformative
THEVI - Overview: Hemoglobinopathy Interpretation
Interpretation of results for the evaluation of thalassemias and hemoglobinopathies Evaluation of microcytosis Extensive and economical diagnosis and classification of hemoglobinopathies or thalassemia including complex...
MMAP - Overview: Methylmalonic Acid, Quantitative, Plasma
Evaluating children with signs and symptoms of methylmalonic acidemia using plasma specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency
MAGU - Overview: Magnesium, 24 Hour, Urine
Assessing the cause of abnormal serum magnesium concentrations using a 24-hour urine collection Determining whether nutritional magnesium loads are adequate Calculating urinary calcium oxalate and calcium phosphate supersaturation and...
HISER - Overview: Histoplasma Antibody Complement Fixation and Immunodiffusion, Serum
Aiding in the diagnosis of active histoplasmosis
IMIPR - Overview: Imipramine and Desipramine, Serum
Monitoring imipramine and desipramine concentrations during therapy Evaluating potential imipramine and desipramine toxicity May aid in evaluating patient compliance
HYPOG - Overview: Hypoglycemic Agent Screen, Serum
Evaluation of suspected insulinoma characterized by hypoglycemia and increased serum insulin concentration Detecting drugs that stimulate insulin secretion Drugs detected by this procedure are: -The first-generation sulfonylureas:...
FIBTP - Overview: Fibrinogen, Plasma
Detecting increased or decreased fibrinogen (factor I) concentration of acquired or congenital origin Monitoring severity and treatment of disseminated intravascular coagulation and fibrinolysis
CLFIB - Overview: Fibrinogen, Clauss, Plasma
Detecting increased or decreased fibrinogen (factor 1) concentration of acquired or congenital origin Monitoring severity and treatment of disseminated intravascular coagulation and fibrinolysis
GQ1ES - Overview: Ganglioside GQ1b Antibody, IgG, ELISA, Serum
Evaluating patients with an underlying demyelinating neuropathy Supporting the diagnosis of a ganglioside GQ1b IgG-related disorder
MMAS - Overview: Methylmalonic Acid, Quantitative, Serum
Evaluating children with signs and symptoms of methylmalonic acidemia using serum specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency
MPA - Overview: Mycophenolic Acid, Serum
Monitoring therapy to ensure adequate blood levels and avoid over-immunosuppression
MEVI - Overview: Methemoglobinemia Interpretation
Interpretation of the methemoglobinemia evaluation results Diagnosis of methemoglobinemia and sulfhemoglobinemia and possible hereditary (congenital) causes Differentiation of methemoglobinemia and sulfhemoglobinemia from other causes of...
OXYCX - Overview: Oxycodone with Metabolite Confirmation, Chain of Custody, Random, Urine
Detection and quantification of oxycodone, oxymorphone, noroxycodone, and noroxymorphone in urine Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the...
PPAP - Overview: Parental Sample Prep for Prenatal Microarray Testing, Blood
Preparing parental blood specimen for possible confirmation testing if an abnormality is detected on the prenatal array sample DNA extraction of the maternal blood specimen used for maternal cell contamination testing
MALCT - Overview: Plasmodium Percent Parasitemia Reflex, Varies
Calculating percent parasitemia, which can be used to predict prognosis and monitor response to treatment for patients with malaria
PTSC - Overview: Prothrombin Time (PT), Plasma
Screening to identify a deficiency of one or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific...
PCAB - Overview: Parietal Cell Antibodies, IgG, Serum
Evaluating patients suspected of having pernicious anemia or autoimmune-mediated deficiency of vitamin B12 with or without megaloblastic anemia
SPAGR - Overview: Special Red Cell Antigen Typing, Whole Blood
Additional proof of alloantibody specificity Determining possible antibody specificities in complex cases This test is not useful for the purpose of establishing paternity
TB2LN - Overview: Susceptibility, Mycobacterium tuberculosis Complex, Second Line, Varies
Determination of Mycobacterium tuberculosis complex minimal inhibitory concentrations to second-line antimicrobial agents
TRYPP - Overview: Tryptophan, Plasma
Investigating inadequate tryptophan intake and monitoring dietary treatment
RHUT - Overview: Rheumatoid Factor, Serum
Diagnosis and prognosis of rheumatoid arthritis
Site Search
Primary ciliary dyskinesia - Insights
Learn more about Mayo Clinic Laboratories’ robust approach to testing for primary ciliary dyskinesia, a rare genetic condition that can lead to chronic otosinopulmonary disease and infertility in men....
https://www.mayocliniclabs.com/it-mmfiles/cpt-code-changes.xlsx
note, CPT Code changes listed on this document are effective January 1st, 2025.*** ***Updates and other changes may occur, and be reflected on this document, leading up to 2025*** ***CPT Code Updates...
CPT Codes and LOINC Update: September 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of September 2019....
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information MC1235297
MCL Primary Ciliary Dyskinesia Genetic Testing Patient Information Complete print Reset Form Primary Ciliary Dyskinesia Genetic Testing Patient Information Instructions Accurate interpretation reporting...
New communication process for CPT Code changes - Insights
Mayo Clinic Laboratories (MCL) is pleased to announce an essential update to our CPT code communication process and website layout. This change is designed to bring timely notifications for accurate billing...